(ZH) Leon Cooperman: "When The Market Finally Goes Down, It Will Move So Fast Yo

Leon Cooperman: "When The Market Finally Goes Down, It Will Move So Fast Your Head Will Spin"

Leon Cooperman is a frequent guest on CNBC, probably because since he only manages his own money, he can more or less say what he pleases without the risk of alienating LPs (though that doesn't seem to bother Kyle Bass, Jeff Gundlach, and other industry big shots who appear on the network). And what we heard Thursday was mostly more of the same from Cooperman, who declared himself a "fully invested bear" while lamenting the idiocy of contemporary markets.
Coop says he's keeping an eye out for "a lot of things...for a signal of change," including Fed Speak, inflation, market action, the action at gold or bitcoin, the dollar exchange rate and interest rates overall.
"Market structure is broken," Cooperman added.
"When there's a real fundamental reason for the market to go down, it's going to go down so fast you're head is going to spin. There's no stabilizing forces in the market right now. When the market goes down, it'll move so fast your head will spin. It's all algorithms."
He acknowledged that his biggest position is a "contrary view", adding that he was long-energy heading into 2021.
"The Fed is creating the environment for this to go forward. There's a theory going around that the government can't allow interest rates to rise because they can't afford it...but I don't buy into that theory. There's got to be an interest on bonds...otherwise there's no financial incentive...I'd rather take a chance on a common stock."
"I don't want to take a chance on a bond, I don't want to see my capital confiscated," he added.
Cooperman expanded on his complaints about the Fed.
"I see a lot of negatives to this interest rate policy" Cooperman complained. If the Fed doesn't normalize rates, the central bank could "lose control" of markets, potentially sending equities into a devastating freefall.
"The Fed is creating the environment to allow this to go forward"
The only certainty in this market, according to Cooperman, is that some day, things will change: "Things will change when it's least expected, but right now the cyclical conditions are in favor of the market."
Cooperman also had some choice words for Treasures, which he dismissed as "totally mispriced" with negative real world rates, and for bitcoin, which Cooperman said "doesn't make a great deal of sense". "I have a great respect for Barry Diller, he was on recently and he said bitcoin is a 'con job'. The one thing I do know is it's not in the interest of the US government to support the development of a rival currency."
The discussion then turned to bitcoin: "if you don't understand bitcoin, it means you're old," Cooperman said.
Cooperman added that bitcoin does not make a great deal of sense, and recommended that investors who are nervous about the world consider investing in gold instead.
"I would be very careful with bitcoin," Cooperman concluded, eliciting laughter and amusement from the crypto community on twitter.

WWD : Valentino CEO Jacopo Venturini on Growing, Repositioning Couture House

Valentino CEO Jacopo Venturini on Growing, Repositioning Couture House
The executive sees strong potential to further grow the company as he reported a 64 percent increase in revenues in the first half compared with the same period last year.

ROME — “I work before I talk, I keep a low profile, it’s my personality.”

With this statement, Jacopo Venturini, chief executive officer of Valentino, laid out his plans for the storied brand for the first time, a year and three months into his job.

The first step after arriving at the company was “to make a strong statement. Valentino is the most established Italian maison de couture, with the strongest heritage,” he said.

This is a pillar for Venturini, which was reflected in his decision to stage Wednesday’s meeting at Valentino’s storied headquarters in Piazza Mignanelli in Rome, a few steps away from the Spanish Steps, followed by a tour of the brand’s couture ateliers. Seamstresses carefully stitched away on dreamy wedding dresses and exquisitely crafted gowns, preserving a tradition that is the jewel in the crown of the brand.

“Two words — maison and couture — open a series of values that create and permeate the culture of the company,” said Venturini in his soft-spoken and affable way. “Returning to Valentino for the third time is a gift life gave me. I felt the brand needed to be repositioned and I needed to make a choice.”

This included the closure of sister brand Red Valentino, which should be completed in two years. “It’s very important to have Valentino under one single label, it’s a strategy that I’ve always had in mind,” he explained.

Venturini was previously executive vice president, merchandising and global markets at Gucci, a role he left in October 2019. After starting his career in fashion at Rinascente as a buyer from 1995 to 1999, he joined Valentino in 2000 as women’s wear and men’s wear brand manager until 2004.

He moved to Prada in 2005 as merchandising coordinator of the women’s wear collection until 2008. That year he returned to Valentino as ready-to-wear collection director and retail image director, staying on until 2015, when he joined Gucci.

He touted “a very strong alchemy from the beginning” with creative director Pierpaolo Piccioli, whom he’s known for 20 years.

A key element is that Valentino “belongs to this [luxury and couture] world, but we are smaller, and this is the advantage,” which allows the brand to grow in a solid way according to its values and culture — one that is becoming increasingly customer-centric, he underscored.

Venturini joined Valentino in June 2020, a few months after the COVID-19 pandemic started to spread globally. The company was not immune to the impact of the health emergency, reporting a net loss of 127 million euros in 2020, compared with a profit of 33 million euros in 2019, on revenues that were down 28 percent to 882 million euros.

However, things are turning around and Venturini said on Wednesday that revenues increased 64 percent in the first half of 2021 to 574 million euros, compared with 362 million euros in the same period last year, and almost flat compared with 2019.

Asked if he expected the company to return to the black in 2021, Venturini said his outlook was positive but that he wanted to wait until the end of the year before providing a definite answer.

The growth in the first half was driven by online sales, the Middle East, U.S. and Greater China regions.

“We are underexposed and have a strong potential to grow in Mainland China,” said Venturini. “In the last year, we started exploring new locations like Shenzhen and we are looking into requalifying locations such as Hangzhou where we are already present.”

In Mainland China there are 27 Valentino directly operated stores and five franchised units.

For example, Valentino selected Greater China to launch its international project called Re-Signify in 2020, presenting the first leg in Shanghai last December. The second part of the brand experience will open in October at SKP in Beijing. The ambition is to reinforce the Valentino codes for the future. “Our approach is humble, we want to tell more about ourselves to the market so that it can get to know us.”

The executive underscored that the goal of the company is to open stores “in a granular way,” reaching customers wherever they are, also through pop-up installations such as the one set up in a partnership with the Phillips Auction House in Southampton, N.Y., to showcase its Valentino Escape 2021 collection in June and July.

The company sees opportunities in Miami and in New Jersey next year. It plans to open a Sydney flagship, whose opening was delayed by the pandemic, and is now expected in 2022. A new mall franchised door is slated to open in Doha next year and Venturini sees new opportunities in Korea, in Lotte Seoul; in Saudi Arabia; in Geneva, Venice, and in Mainland China in new cities such as Shenzhen in 2022; in Guangzhou, and in Wuhan in 2023.

Valentino has a total of 225 stores, of which 196 are directly operated.

Retail and wholesale sales account for 55 and 45 percent of total revenues, respectively, but Venturini’s goal is to have retail reach 70 percent of revenues in the next five years. “Wholesale can give visibility and create stimulating partnerships, but we believe we have to be more selective and choose the right partners for more visibility,” he contended.

The company is also working on a new store concept, he added.

E-commerce has been growing at a triple-digit pace and Venturini said that the combination of a more engaging e-commerce and an omnichannel strategy allowed the company to see an increase in online penetration from 5 percent in 2019 to 15 percent in 2020, and “it is still growing at the moment.”

Venturini was also asked about the rumors that repeatedly surround Valentino, such as a possible sale by owner Mayhoola, potential acquisitions or an initial public offering. He deferred the answer to the owners of the brand. In March, a Mayhoola spokesperson said “there is no desire to take into consideration selling Valentino , we are fully committed to the brand and the company’s success. Also, there is no intention of launching an IPO in the near future.“

Venturini reiterated that all production is made in Italy and that Valentino has through the years set up joint ventures for the manufacture of shoes and bags. “We have a good structure,” he said.

Valentino has two licenses, for eyewear with Luxottica and for beauty and fragrances with L’Oréal. Venturini said that the launch of the Voce Viva fragrance fronted by Lady Gaga last September and of its makeup in June “overachieved expectations.”

He admitted there were plans to expand the product portfolio but said it needed to be done “step by step” and consistently with the brand’s “genuine and spontaneous path. I like its authenticity, we are not merely following opportunities.”

Accessories helped drive business in the first half, but the company is expanding its ready-to-wear in daywear, he said, with more separates, “while protecting the business of eveningwear.” Men’s wear, which Piccioli unveiled also for couture for spring 2021, is also growing, now accounting for 20 percent of sales.

Venturini emphasized that creativity, human capital and team work were at the center of his attention and main drivers of the company’s evolution. He underscored the value of relationships between the brand, its sales force and the customers, with Valentino’s couture values and attention to details trickling down to the whole company. “We are also creating a colleague-centric company, where everyone is a customer.”

He has been busy building a new C-suite, ranging from chief client and digital acquisition officer Enzo Quarenghi, who joined in January, to new chief human resources officer Rosa Santamaria Maurizio, for example.

He cited Alessio Vannetti, chief brand officer, who with his team has been creating strong bonds with customers through music, cinema and other activities outside fashion, “assimilated to the entertainment world.” He cited the Chez Maison Valentino immersive digital experience in the historical headquarters that illustrates a 2D facade of Palazzo Mignanelli, designed by illustrator Joana Avillez, where clients can click on each window to discover content about the brand’s heritage, for example.

“We filled the lack of physical relationships that resulted in a general increase of time spent, up 55 percent and engagement compared to the average of the site,” he observed.

With Marco Giacometti, chief commercial officer, Venturini is “re-energizing the store network changing the role of our client advisers who are becoming real brand ambassadors capable in creating unique and deep connections with our clients.”

Venturini also approached the subject of sustainability, which “is not a marketing tool, but a reality,” he said.

Valentino back in 2013 joined the Greenpeace Detox Solution Commitment in a mission to eliminate all dangerous chemicals from its supply chain and signed onto Zero Deforestation Commitment projects to help protect life-giving waterways and rainforests. “As a result of our commitment with Greenpeace we have reduced by approximately 63 percent the chemical substances in our production,” the CEO said.

As reported, Valentino has committed to going fur-free starting from 2022 and alpaca-free starting with the spring 2022 season. It is also working with environmentally friendly viscose suppliers for 70 percent of its production.

A new shoe made with recycled elements, the Open for a Change sneaker for men and women, will be available starting from December. “Lastly, we are ready to deliver a new product packaging set to launch this fall which will be sustainable for at least 55 percent,” he said.

FT : Amazon-backed biotech Mammoth raises $200m for diseases push

Amazon-backed biotech Mammoth raises $200m for diseases push
California group co-founded by Nobel Prize winner Jennifer Doudna seeks to expand use of gene-editing tool

Mammoth Biosciences, the biotech co-founded by Nobel Prize winner Jennifer Doudna and that counts Amazon as a backer, has raised almost $200m to expand its use of novel Crispr-associated proteins into an effort to cure genetic diseases. 

The California-based start-up is now valued at $1bn following a $150m round led by venture capitalists Redmile Group, with participation from Foresite Capital. It follows a $45m fundraising the company had in late 2020.

Mammoth hunts the world for new versions of the bacterial immune system that can be used as a gene-editing tool known as Crispr, or clustered regularly interspaced short palindromic repeats. 

Its discovery of new smaller proteins associated with Crispr have already enabled novel diagnostics, including cheap and accurate Covid-19 tests, and may be more effective at delivering the editing tool as a treatment into the body, also known as “in vivo”. 

Doudna, who won the Nobel Prize for co-discovering Crispr with her colleague Emanuelle Charpentier, said Mammoth is in a “unique position” to enable novel treatments and diagnostic tools. 

“An exciting example is Mammoth’s ultra-small CRISPR systems that advance in vivo delivery options that can dramatically improve the lives of patients.”

Mammoth is now working with a network of microbe hunters who scour volcanoes, sewers and polluted wastelands, as well as re-examining existing data sets, for previously unnoticed proteins. Lucas Harrington, co-founder and chief scientific officer, said nature has done quite a bit of the “heavy lifting” to create these systems. 

“This is a natural tool that is out there protecting bacteria and there’s actually tens of thousands of different versions of it that are out in nature,” he said. 

Most other Crispr biotech companies are focused on the initial discovery of the Crispr-associated protein nine. But Mammoth wants to be able to offer a “menu of Crispr systems”, Harrington said.

“We definitely believe that it’s not a one-size fits all solution. I think that’s been the approach with CAS9 so far is that you have one protein, and it’s going to work for everything,” he said. 

In diagnostics, Mammoth is working with UK drugmaker GlaxoSmithKline, the US National Institutes of Health, and Defense Advanced Research Projects Agency to develop tests for a broad range of infectious diseases. 

Trevor Martin, Mammoth’s chief executive, said that at present people have to choose between a result that is really accurate, such as a PCR test, or rapid, like a lateral flow test.

“Where we really see that kind of long-term promise of Crispr as a diagnostic tool is in smashing that kind of choice and really being able to have something that is [an] extremely powerful, molecular result but in a very accessible format,” he said.

(ZH) Turmoil In SPAC Mergers

Turmoil In SPAC Mergers

Summary
  • SPACs generally underperform after their mergers.
  • Shorting SPACs over the merger date can lead to short squeezes, making arbitraging SPAC underperformance impossible.
  • This will likely persist as a permanent inefficiency in the market.
We have previously written about SPACs and overblown talk of a SPAC crash. While exuberance has since left the SPAC space, investors with excessively negative positioning in SPACs recently took losses. This shows that SPACs remain a niche where it pays to tread carefully.
De-SPAC short squeeze
As we wrote in April, SPACs tend to jump temporarily once a merger has been announced. Over the three months after a merger, they underperform the Russell 2000 by 12%. To put it more bluntly: many SPACs fall below the original $10 cash level after a merger.
This happens for several reasons: once the merger is done, the original shareholders are diluted by the shares given to the owners of the target company. These shares were often issued at inflated valuations, so that the overall per share value post-merger is lower than the $10 cash value of the acquirer. To make matters worse, SPAC holders have the right to redeem their shares for cash, which many of them do. The end result is that following the SPAC merger, the remaining shareholders find themselves with a business that is overvalued and has little of the original SPAC cash left. Not surprisingly, many shares fall below the $10 level.
Compelling short?
It did not take long for investors to understand this dynamic. To profit from it, some investors short shares in a SPAC just before it completes the merger. Once completed, most SPAC shares soon fall below the $10 level, generating profits for the shorts.
Of course, there are no risk-free profits in finance, and recently, the risks embedded in this strategy have become apparent as shorts suffered heavy losses. This is due to another feature of SPACs. More precisely, the feature that makes SPACs today safer for investors than the predecessors of yore: the ability to redeem SPAC shares in the merger. SPAC investors who do not like the SPAC merger can redeem their shares for their pro rata share of IPO proceeds held in trust, plus interest. That is generally a little more than $10 per share. Recently, many shareholders have taken advantage of these features, as the business models of SPAC merger candidates are frequently deemed to be lacking.
Short squeeze
These SPAC redemptions cause a problem for short sellers: if a shareholder who has lent their shares to a short seller requests a SPAC redemption, these shares are withdrawn and the short seller gets a buy-in notice. A quarter of all SPACs have had redemption rates of 80% or higher [i]. This has led to some spectacular short squeezes.
For example, Blue Water Acquisition Corporation, a SPAC that was targeting private companies in the biotech and life science space in the $80 to $300m deal range, completed its merger with Clarus Therapeutics on August 27. The day prior to closing, the stock traded up from a close of $10.33 to an intraday high of $31.24. Within days, it was back to the $10 range and closed on Friday at $7.66. Therefore, the thesis of short sellers was correct – post-merger, the SPAC would be worth substantially less than the amount of cash originally held in trust. However, as a result of the short squeeze, many shorts are likely to have lost money.
This episode illustrates not just problems that short sellers face in general – as anyone who has followed the GameStop saga is well aware – but also the intricacies and inefficiencies inherent in SPACs. Even though SPAC underperformance is a systematic issue, it cannot be arbitraged easily due to the limited availability of shares to short. Therefore, we expect this phenomenon to persist as a permanent inefficiency in the market.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • BASE -15.7%, SAM -9.3% (withdraws guidance; expects EPS to fall below prior guidance), ABM -9%, GME -8.3%, AVAV -7.6%, CVGW -4.6% (also CEO to retire), S -2.3%, JG -1.4%

Other news:

  • HGEN -58% (FDA denies Emergency Use Authorization request for Lenzilumab)
  • APLT -8.5% (reports initial biomarker data from the pediatric ACTION-Galactosemia Kids study)
  • CERT -7.1% (prices offering of 4.5 mln shares of common stock at $31.00 per share)
  • SKIN -5.5% (convertible notes offering)
  • DLR -4.2% (prices offering of 6.25 mln shares of common stock at $160.50 per share)
  • VICI -3.5% (stock offering; also files mixed securities shelf offering)
  • BBCP -2.8% (acquires Hi-Tech Concrete Pumping Services)
  • BIGC -2.5% (convertible notes offering)
  • FTAI -2.4% (stock offering)
  • TMUS -2.2% (indicated lower on block trade pricing)
  • GEVO -2.2% (entered into an amendment to the At-The-Market Offering Agreement)
  • SNY -1.6% (reports Phase 3 study of rilzabrutinib did not meet primary endpoint )
  • TSN -0.9% (Categorically Rejects Conclusions Drawn by White House)
  • UAL -0.8% (provides updates; has seen in the last few weeks a deceleration in customer bookings vs previous estimations due to the recent spike in COVID-19 cases associated with the Delta variant)
  • LUV -0.7% (lowers Q3 operating revenue outlook)

Analyst comments:

  • ES -2.1% (downgraded to Underperform from Neutral at Mizuho)
  • AXTA -1.6% (downgraded to Neutral from Buy at Citigroup)
  • CSCO -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • CURV +16.2%, LULU +13.2%, LOVE +11%, RKLB +5.7% (also awarded multi-launch deal to deploy IoT satellite constellation for Kinéis), RH +2.3%, ASX +2.3% (Aug revs) SHCR +2.3%, HQY +1.2%, JILL +1%, .

Other news:

  • CRDF +16% (announces Phase 1b/2 trial data showing robust objective response rate and progression free survival)
  • CNTA +15.4% (reports topline data from proof-of-concept study of SerpinPC in severe hemophilia A and B patients)
  • PRQR +14.5% (announces licensing and research collaboration with LLY for Axiomer RNA editing)
  • SIOX +5.3% (doses first GM1 Gangliosidosis early infantile patient in ongoing Phase 1/2 study of AXO-AAV-GM1 gene therapy)
  • RKLY +3.6% (expands application of non-invasive biomarker sensing technology)
  • BYSI +3.4% (Three Poster Presentations About its Chemotherapy-Induced Neutropenia Prevention Program at the European Society for Medical Oncology 2021 Congress)
  • CLSD +2.9% (to expand the territories covered by its exclusive license agreement with Arctic Vision)
  • CHRA +2.6% (awarded 5-year fly ash sales and marketing contract for beneficial use of production fly ash at gavin power plant in Ohio)
  • ZYNE +1.6% (presents data from the Phase 2 BRIGHT trial)
  • NXU +1.5% (Energy Vault to accelerate global decarbonization, to list on the NYSE through merger with Novus Capital Corporation II)
  • RIOT +1.2% (reports August production and operation updates)
  • RYTM +1.2% (announces EAP for setmelanotide)
  • TPTX +1.1% (to present abstract of early clinical data from TRIDENT-1)
  • EVLO +1% (U.S. Patent and Trademark Office has issued a new composition of matter patent (No. 11,090,341) for medicines comprising pharmaceutical compositions of Veillonella parvula bacteria)

Analyst comments:

  • APP +2.8% (upgraded to Buy from Hold at Stifel)
  • BMRN +1.7% (upgraded to Buy from Hold at Stifel)
  • M +0.9% (upgraded to Outperform from Market Perform at Cowen)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • CRDF +18.6%, LULU +13.9%, PRQR +13.7%, CURV +12.9%, RKLB +5.4%, RKLY +3.6%, RIOT +1.9%, RH +1.5%, CPRT +1.3%, RYTM +1.2%, ASX +0.8%, TRN +0.5%
  • Gapping down:
    • HGEN -55.2%, BASE -12.2%, DSGX -10.9%, CERT -9.1%, SAM -8.8%, GME -7.2%, ABM -4.3%, AVAV -4.3%, SKIN -4.2%, JG -4.2%, DLR -3.6%, TMUS -3.3%, VICI -3%, BBCP -2.8%, CVGW -2.7%, FTAI -2.4%, S -2.2%, BIGC -2.1%, SNY -2%, TSN -2%, UAL -2%, HQY -1.9%, LICY -1.4%, F -1.2%

FT : Tencent and NetEase shares fall as China urges end to profit focus in gamin

Tencent and NetEase shares fall as China urges end to profit focus in gaming
Beijing warns tech companies over ‘erroneous tendencies’ in latest assault on sector


Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.

Shares in Tencent and NetEase fell sharply after authorities ordered the Chinese technology companies to pivot from focusing on profits in online gaming and on reports that Beijing had halted approvals for new games.

China’s two leading gaming companies were summoned for talks on Wednesday in Beijing, in which top officials asked them to “profoundly understand the importance and urgency of preventing minors from online game addiction”, according to Xinhua, the state news service.

Hong Kong-listed shares in NetEase and Tencent closed 11 and 8.5 per cent lower respectively on Thursday, with losses escalating after the South China Morning Post reported the companies were informed at the meeting that approvals for all new online games had been suspended.

The Hang Seng Tech index, which tracks the largest tech groups listed in the city, shed 4.7 per cent.

The losses followed a sell-off in New York-listed Chinese tech shares. The Nasdaq Golden Dragon index of large US-listed Chinese stocks closed 3.4 per cent lower, its worst performance in more than three weeks.

The meeting in Beijing marked authorities’ latest assault on China’s tech sector. The stocks had experienced a tentative recovery as the steady drumbeat of punitive measures slowed following Beijing’s announcement in late August that it would limit children to three hours of gaming a week.

But the Chinese Communist party’s publicity department and government regulators, including the national press and publication administration, renewed the regulatory pressure. They urged online gaming companies “to break from the solitary focus of pursuing profit or attracting fans and other erroneous tendencies, and change game rules and designs inducing addictions”, according to Xinhua.

Ke Yan, an analyst with DZT Research who writes on the Smartkarma platform, said the comments were part of the government’s “continuous effort of fine-tuning the online game industry”.

“No details were given how they are going to stop the dominance of Tencent and NetEase,” Ke said, adding that the guidance around preventing monopolistic behaviour “impacts the big players”.

Connie Gu, an analyst with China’s Bank of Communications, said a delay in the release in China of Tencent’s League of Legends: Wild Rift, announced by the company on Thursday morning, also factored in to the share price dip. “The League of Legends game should be [of] benefit to revenue, but since the delay, the market [was] concerned,” she said.

Tencent, which has come under regulatory pressure over its lucrative Honor of Kings mobile game in recent months, said it took the physical and mental health of minors “very seriously”.

“We appreciate the guidance and instruction from the relevant regulators, and will work hard to be in full compliance with all rules relating to youth game addiction and content regulation,” the company said.

NetEase said it planned to “strictly follow” anti-addiction rules and instructions in regards to gaming for minors. “We seek to build and promote a wholesome gaming environment in China,” the company said.

The report that new online games had been suspended could not immediately be confirmed. But, in an unusual delay, the National Press and Publication Administration, the regulator in charge of online game approvals, is yet to publish its figures for the month of August.

Ke, from DZT Research, said it was possible there was a slowdown in game approvals by the regulator. “More than a year ago it was around one to two a month, now it is like one [every] few months for Tencent,” Ke said.

Technology companies also face a regulatory onslaught from provincial governments. On Wednesday, a group of Tianjin government officials called in riding-hailing company Didi Chuxing and seven competitors to discuss lax health and safety procedures, mistreatment of drivers and illegal pricing. 

FT : Germany’s stock market needs deeper change

Germany’s stock market needs deeper change
Adding 10 companies does not go far enough to overhaul the Dax 30

That there has been little argument over expanding Germany’s Dax 30 index of blue-chip stocks to a Dax 40 reflects a fundamental problem with the reform. Including 10 more companies makes the index more diverse for investors and provides a showcase for more of the country’s companies. Yet the lack of controversy reflects a lack of ambition: deeper change is ultimately needed to create an equity market fit for Europe’s largest economy.

The expansion, from later this month, follows a consultation by the Dax operator, Deutsche Börse Group, on how to improve stock markets after the Wirecard accounting fraud. As well as increasing Frankfurt’s appeal as a listing destination for fast growing technology companies, there are other reasons to revamp Germany’s equities scene: the eurozone needs deeper financial markets to replace the City of London after Brexit. Equities need a particular boost given the bloc’s dependence on debt financing.

Germany is no laggard in innovation. Its industrial behemoths are among the world’s biggest investors in research and development, its universities and research institutes count armfuls of patents among their achievements. It is home to BioNTech, creator of one the first successful coronavirus vaccines.

That continued strength in cutting-edge research is not reflected in the Dax 30, considered by many international investors an outdated list of past successes: SAP, founded in the 1970s, is the only software company in an index made up mostly of chemicals, pharmaceutical and automotive companies. That the Dax measures the total return from its members — both share price growth and dividends — adds to the retro feel. Successful German start-ups, such as BioNTech and its peer CureVac, head to New York and the tech-focused Nasdaq to list.

Given the implosion of the Neuer Markt, Germany’s attempt to create a homegrown answer to Nasdaq in the 1990s, some caution from Deutsche Börse might be excused. But the requirement that companies must have two years of profit to be eligible for inclusion will limit the Dax 40’s scope to showcase more German tech companies. That partly reflects a backlash from often dividend-focused domestic investors after the inclusion of the lossmaking start-up Delivery Hero. Many successful start-ups, however, have not made a profit for years while giving shareholders a decent return through price appreciation.

Many Germans may be proud of their more consensual form of capitalism, without the brash boosterism of Silicon Valley, but tech entrepreneurs need to shout loud to be heard. DeepL, a Cologne-based rival to Google Translate, is little heard of outside the country, as is TeamViewer, a provider of video conferencing software. Without a visible tech-focused alternative to the Dax 30, promising start-ups must begin at the very bottom and gradually climb their way into the established corporate aristocracy.

An opportunity has also been missed to improve governance. Both the Wirecard debacle and the emissions scandal at VW were facilitated in part by weak oversight and governance exceptionalism. Yet the Dax 40 project does little to strengthen the independence of non-executives or the supervisory board structures they operate within.

Germany’s version of capitalism is a success story but it is hard now to find a Dax member that is not facing a dramatic transition over the next few years, from Deutsche Bank’s long-running travails to carmakers and energy companies coping with climate change. Reinvigorating its market requires more than adding 10 extra companies.